|
1
|
Plymoth A, Viviani S and Hainaut P:
Control of hepatocellular carcinoma through hepatitis B vaccination
in areas of high endemicity: perspectives for global liver cancer
prevention. Cancer Lett. 286:15–21. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li H, Zhang Y, Su T, et al: Hint1 is a
haplo-insufficient tumor suppressor in mice. Oncogene. 25:713–721.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang L, Li H, Zhang Y, et al: HINT1
inhibits beta-catenin/TCF4, USF2 and NFkappaB activity in human
hepatoma cells. Int J Cancer. 124:1526–1534. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Negrini M, Monaco C, Vorechovsky I, et al:
The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Cancer
Res. 56:3173–3179. 1996.
|
|
5
|
Bugert P, Wilhelm M and Kovacs G: FHIT
gene and the FRA3B region are not involved in the genetics of renal
cell carcinomas. Genes Chromosomes Cancer. 20:9–15. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sugimoto K, Yamada K, Miyagawa K, et al:
Decreased or altered expression of the FHIT gene in human
leukemias. Stem Cells. 15:223–228. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tanaka H, Shimada Y, Harada H, et al:
Methylation of the 5′ CpG island of the FHIT gene is closely
associated with transcriptional inactivation in esophageal squamous
cell carcinomas. Cancer Res. 58:3429–3434. 1998.
|
|
8
|
Croce CM, Sozzi G and Huebner K: Role of
FHIT in human cancer. J Clin Oncol. 17:1618–1624. 1999.PubMed/NCBI
|
|
9
|
Simon B, Bartsch D, Barth P, et al:
Frequent abnormalities of the putative tumor suppressor gene FHIT
at 3p14.2 in pancreatic carcinoma cell lines. Cancer Res.
58:1583–1587. 1998.PubMed/NCBI
|
|
10
|
Calvisi DF, Conner EA, Ladu S, et al:
Activation of the canonical Wnt/beta-catenin pathway confers growth
advantages in c-Myc/E2F1 transgenic mouse model of liver cancer. J
Hepatol. 42:842–849. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Behari J, Zeng G, Otruba W, et al:
R-Etodolac decreases beta-catenin levels along with survival and
proliferation of hepatoma cells. J Hepatol. 46:849–857. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Monga SP: Role of Wnt/beta-catenin
signaling in liver metabolism and cancer. Int J Biochem Cell Biol.
43:1021–1029. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee HS, Park MH, Yang SJ, et al: Novel
candidate targets of Wnt/beta-catenin signaling in hepatoma cells.
Life Sci. 80:690–698. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang L, Zhang Y, Li H, et al: Hint1
inhibits growth and activator protein-1 activity in human colon
cancer cells. Cancer Res. 67:4700–4708. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zöchbauer-Müller S, Fong KM, Maitra A, et
al: 5′ CpG island methylation of the FHIT gene is correlated with
loss of gene expression in lung and breast cancer. Cancer Res.
61:3581–3585. 2001.
|
|
16
|
Ohta M, Inoue H, Cotticelli MG, et al: The
FHIT gene, spanning the chromosome 3p14.2 fragile site and renal
carcinoma-associated t(3;8) breakpoint, is abnormal in digestive
tract cancers. Cell. 84:587–597. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zheng S, Ma X, Zhang L, et al:
Hypermethylation of the 5′ CpG island of the FHIT gene is
associated with hyperdiploid and translocation-negative subtypes of
pediatric leukemia. Cancer Res. 64:2000–2006. 2004.
|
|
18
|
Yang Q, Nakamura M, Nakamura Y, et al:
Two-hit inactivation of FHIT by loss of heterozygosity and
hypermethylation in breast cancer. Clin Cancer Res. 8:2890–2893.
2002.PubMed/NCBI
|
|
19
|
Leal MF, Lima EM, Silva PN, et al:
Promoter hypermethylation of CDH1, FHIT, MTAP and PLAGL1 in gastric
adenocarcinoma in individuals from Northern Brazil. World J
Gastroenterol. 13:2568–2574. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mirandola P, Gobbi G, Sponzilli I, et al:
TRAIL-induced apoptosis of FHIT-negative lung cancer cells is
inhibited by FHIT re-expression. J Cell Physiol. 220:492–498. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Werner NS, Siprashvili Z, Fong LY, et al:
Differential susceptibility of renal carcinoma cell lines to tumor
suppression by exogenous Fhit expression. Cancer Res. 60:2780–2785.
2000.PubMed/NCBI
|
|
22
|
Sevignani C, Calin GA, Cesari R, et al:
Restoration of fragile histidine triad (FHIT) expression induces
apoptosis and suppresses tumorigenicity in breast cancer cell
lines. Cancer Res. 63:1183–1187. 2003.PubMed/NCBI
|
|
23
|
Zheng H, Tsuneyama K, Takahashi H, et al:
Expression of PTEN and FHIT is involved in regulating the balance
between apoptosis and proliferation in lung carcinomas. Anticancer
Res. 27:575–581. 2007.PubMed/NCBI
|
|
24
|
Li H, Balajee AS, Su T, et al: The HINT1
tumor suppressor regulates both gamma-H2AX and ATM in response to
DNA damage. J Cell Biol. 183:253–265. 2008. View Article : Google Scholar : PubMed/NCBI
|
